MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--Rainbow BioSciences, the biotech division of Rainbow Coral Corp. (OTCBB: RBCC) announced today that it has initiated talks with a drug development company pursuing a promising new therapy for Parkinson’s disease.
